ASRS 2023: Fernando Arevalo on retinal detachments associated to retinoschisis
August 3rd 2023Fernando Arevalo, MD, PhD, FACS, FASRS, shared information on his presentation on the treatment of progressively symptomatic retinal detachments associated to retinoschisis cases at the 2023 ASRS annual meeting.
ASRS 2023: 27-Gauge vs 25-gauge vitrectomy for symptomatic vitreous opacities
August 2nd 2023Our team spoke with Shawn Kavoussi, MD, at the 2023 ASRS meeting in Seattle, Washington about his research on using infrared video for vitreous opacities and comparing postoperative reduction in vitreous opacity scores using infrared video with the Heidelberg spectralis unit.
ASRS 2023: Michael Ip, MD, on key trends and perspectives from the 2023 meeting in Seattle
August 1st 2023Michael Ip, MD, spoke with our team at the 2023 ASRS meeting in Seattle, Washington. He noted presentations and trends that are key at this event and why they're vital to a modern view of ophthalmology.
ASRS 2023: 'MacGyver-Inspired' endolaser option for chandelier-assisted scleral buckles
July 31st 2023Richard B. Rosen, MD, shared insights from his presentation from ASRS 2023 on "New 'MacGyver-inspired' endolaser option for chandelier-assisted scleral buckles" with Sheryl Stevenson, our Group Editorial Director.
ASRS 2023: Sharing outcomes and clinical features predictive of fungal endophthalmitis
July 29th 2023Mark Breazzano, MD, FACS, who is presenting Outcomes and Clinical Features Predictive of Fungal Endophthalmitis at the 2023 ASRS meeting in Seattle, Washington spoke with our team about this research.
Key Retreatment Decisions in the Clinical Trials for Faricimab in nAMD
July 21st 2023Dr Varun Chaudhary presents the retreatment decisions during the treat-and-extend phase of the TENAYA and LUCERNE clinical trials in neovascular AMD, focusing on the percentage of patients who maintained, extended, or reduced their treatment interval based on visual and anatomic criteria.
SOE 2023: What new surgeries will hit the glaucoma market?
June 17th 2023Ophthalmology Times Europe© is proud to cover the European Society of Ophthalmology 2023. We spoke to SOE presenter Panayiota Founti, PhD, FEBO, Consultant Ophthalmic Surgeon & Training Director, Glaucoma Service Moorfields Eye Hospital, London, UK.
COPHy 2023: Presence of macular neovascularisation on OCTA is predictive of subsequent exudation
March 24th 2023Angela Carneiro, MD, PhD, discusses her position on a discussion titled Presence of Macular Neovascularization on OCTA is Predictive of Subsequent Exudation with David Hutton, Executive Editor, Ophthalmology Times®.